Table 1.
Baseline sociodemographic and clinical characteristics of the intervention and control groups including dropouts
| Characteristics | Intervention group | Control group | Dropouts |
|---|---|---|---|
| (n = 47) | (n = 50) | (n = 10) | |
| Sex | |||
| Male | 21 (45%) | 22 (44%) | 3 (30%) |
| Female | 26 (55%) | 28 (56%) | 7 (70%) |
| Age (years) | |||
| Mean age (sd) | 55·0 (12·3) | 55·8 (13·2) | 51·1 (16·0) |
| Range | 34–81 | 21–77 | 24–70 |
| Civil status | |||
| Living alone | 12 (26%) | 11 (22%) | 4 (40%) |
| Co-habiting | 35 (74%) | 39 (78%) | 6 (60%) |
| Education | |||
| Primary school | 15 (32%) | 14 (28%) | 5 (50%) |
| Secondary school | 15 (32%) | 15 (30%) | 3 (30%) |
| Third level education | 17 (36%) | 21 (42%) | 2 (20%) |
| Rheumatic disease | |||
| Rheumatoid arthritis (RA) | 25 (53%) | 35 (70%) | 8 (80%) |
| Undifferentiated arthritis (UA) | 1 (2%) | 3 (6%) | 0 |
| Undifferentiated spondyloarthritis (USpA) | 10 (21%) | 6 (12%) | 1 (10%) |
| Peripheral psoriatic arthritis (PsA) | 11 (23%) | 6 (12%) | 1 (10%) |
| Disease duration (years) | |||
| Mean disease duration (sd) | 17·3 (10·9) | 16·2 (12·1) | 14·0 (6·9) |
| Range | 1–44 | 1–52 | 1–21 |
| Disease activity DAS28 | |||
| Mean (sd) | 1·97 (0·67) | 2·14 (0·71) | 2·39 (0·60) |
| Range | 0·61–3·20 | 0·53–3·06 | 1·47–3·13 |
| Disease activity DAS28-CRP | |||
| Mean (sd) | 2·43 (0·58) | 2·53 (0·64) | 2·65 (0·49) |
| Range | 1·74–4·10 | 1·71–4·12 | 2·02–3·23 |
| Health Assessment Questionnaire (HAQ) | |||
| Mean (sd) | 0·45 (0·42) | 0·63 (0·55) | 0·43 (0·59) |
| Range | 0–2·13 | 0–2·50 | 0–1·88 |
| VAS Pain (mm) | |||
| Mean (sd) | 17·8 (11·5) | 24·2 (22·2) | 17·2 (16·9) |
| Range | 0–48 | 0–79 | 0–59 |
| Satisfaction (0–10) | |||
| Mean (sd) | 9·6 (0·80) | 9·4 (1·28) | 9·8 (0·42) |
| Range | 7–10 | 3–10 | 9–10 |
| Confidence (0–10) | |||
| Mean (sd) | 9·7 (0·66) | 9·3 (1·45) | 9·8 (0·63) |
| Range | 7–10 | 2–10 | 8–10 |